BackLumos Pharma Overview

Lumos Pharma Other Current Liabilities

Latest other current liabilities for LUMO: $4.9M.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$4.92M
↓ 10.58% YoYΔ $-582000.00 vs prior year quarter

Peer trimmed avg / median

Loading

Lumos Pharma Other Current Liabilities History

Loading

Lumos Pharma vs. peers: Other Current Liabilities Comparison

Loading

Lumos Pharma Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Lumos Pharma (LUMO) FAQ

As of the most recent data (September 2024), LUMO shows a other current liabilities of $4.9M. That compares with $5.5M in the prior-year period — down 10.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, LUMO's other current liabilities is now $4.9M (was $5.5M) — a 10.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Lumos Pharma is outperforming or lagging.

Tracking LUMO's other current liabilities over time shows whether Lumos Pharma is scaling, shrinking, or reshaping that part of the business. The current reading is $4.9M That compares with $5.5M in the prior-year period — down 10.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current liabilities page, Stockcircle has Lumos Pharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current liabilities (currently $4.9M) with ownership activity and broader fundamentals.

Lumos Pharma's other current liabilities is $4.9M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.